Virtus ETF Advisers LLC Atreca, Inc. Transaction History

Virtus ETF Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $58,757 - $128,775	-20,473 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $5,288 - $9,768	-1,077 Reduced 5.0%	20,473 $128,000
Q2 2021 Aug 10, 2021	BUY	$7.82 - $13.8 $28,887 - $50,977	3,694 Added 20.69%	21,550 $184,000
Q1 2021 May 17, 2021	BUY	$13.0 - $19.34 $3,978 - $5,918	306 Added 1.74%	17,856 $274,000
Q4 2020 Feb 12, 2021	SELL	$13.03 - $17.09 $1,680 - $2,204	-129 Reduced 0.73%	17,550 $283,000
Q3 2020 Nov 13, 2020	SELL	$12.67 - $23.19 $30,496 - $55,818	-2,407 Reduced 11.98%	17,679 $247,000
Q2 2020 Aug 05, 2020	BUY	$12.52 - $23.45 $251,476 - $471,016	20,086 New	20,086 $427,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.